IXC 6.17% 8.6¢ invex therapeutics ltd

I could eat my words here, but I really don't think ozempic is...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 795 Posts.
    lightbulb Created with Sketch. 45
    I could eat my words here, but I really don't think ozempic is relevant here. It hasn't been shown to reduce ICP and presendin hasn't been shown to aid in weight loss. The issue in my opinion is lumbar puncture and the prospect of being on a placebo for 24 weeks. Coupled with the currently rigorous diagnostic criteria to admit patients as I said a few days ago. If management decides to half the trial size and admit a wider variety of patients *hopefully* it will still show efficacy
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.